Parathyroid Neoplasms clinical trials

The registry lists 63 studies for Parathyroid Neoplasms across more than 10 countries. 19 are recruiting or about to start. 28 of them are mainly about Parathyroid Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.

Get an email when these change. Save the Parathyroid Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 31
Recruiting: 10
Enrolling by invitation: 4
Status unknown: 4
Active, not recruiting: 4
Not yet recruiting: 4

Phase

Phase 2: 9
Phase 1: 8
Phase 3: 6
Phase 4: 3
Early Phase 1: 1

Where

United States: 29
France: 5
Italy: 5
Canada: 3
Israel: 2
Denmark: 2

Who runs them

National Cancer Institute (NCI) (5) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (4) · M.D. Anderson Cancer Center (4) · Aristotle University Of Thessaloniki (3) · Kyowa Kirin Co., Ltd. (2) · Amgen (2) · Valerio Therapeutics (2) · European Organisation for Research and Treatment of Cancer - EORTC (1)

What is being tested here

Drugs under test in Parathyroid Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Liposomal Bupivacaine	1	0	1
Bupivacaine	1	0	1
Lenvatinib	1	0	1
Cinacalcet	0	2	3
Nivolumab	0	0	2
Denosumab	0	1	2
Belinostat	0	0	2
Ipilimumab	0	0	1
Gallium Ga 68 dotatate	0	0	1
Evocalcet	0	1	1

Drug classes tested here HDAC inhibitors 3

Coming up

2phase 3 studies under way

4studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4, phase 3 first

Jul 202799mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT · Phase 3 · Andrei Iagaru
Jan 2027High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins · Algemeen Ziekenhuis Maria Middelares
Jul 2027Agnostic Therapy in Rare Solid Tumors · Instituto do Cancer do Estado de São Paulo
Sep 2027Parathyroid Adenoma Detection With Rubidium-82 Imaging · Matthieu Pelletier-Galarneau, MD MSc

Who these studies take

Of the 10 Parathyroid Neoplasms studies recruiting now, 7 (70%) set no upper age limit and 0 (0%) stop at 75 or younger. 4 (40%) take children under 18. 1 (10%) are for women only and 0 (0%) for men only; 1 (10%) take healthy volunteers.

Recruiting studies that take each age, of 10
Age	Women	Men
10	4 (40%)	4 (40%)
18	10 (100%)	9 (90%)
30	10 (100%)	9 (90%)
40	10 (100%)	9 (90%)
50	10 (100%)	9 (90%)
65	10 (100%)	9 (90%)
75	10 (100%)	9 (90%)
85	9 (90%)	9 (90%)

Across all 63 studies, recruiting or not: 2% stop at 75 or younger and 0% at 65; 22% take children; 2% are for women only and 0% for men only; 6% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 63. Browse all 63 → or search them.